Logo

FDA Approves Third Tocilizumab Biosimilar

FDA Approves Third Tocilizumab Biosimilar

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as the originator tocilizumab, Actemra.

👉 Full Story